UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GSK to host drive-thru symposium on respiratory disease
GSK said Friday that it would hold a drive-through symposium at Jamsil Driv...
by Shim Hyun-tai
|
2020-05-08 16:34
라인
‘Roche’s Kadcyla allows early breast cancer patients to continue social life’
Roche Korea obtained additional indication approval for Kadcyla (ingredient...
by Kim Yun-mi
|
2020-05-08 15:51
라인
GC joins global plasma alliance to develop Covid-19 therapy
GC said that it has joined the CoVIg-19 Plasma Alliance, composed of global...
by Lee Han-soo
|
2020-05-08 15:45
라인
Hanmi applies for market launch of Korea’s 1st new bio-drug
Hanmi Pharmaceutical submitted a new drug approval application for Rolontis...
by Lee Han-soo
|
2020-05-08 15:45
라인
Arrest warrant sought for Sillajen’s CEO
Prosecutors have requested a court to issue an arrest warrant for Sillajen ...
by Lee Han-soo
|
2020-05-08 15:43
라인
Daewoong’s BTX sales growth offset by lawsuit expenses
Daewoong Pharmaceutical earned 13.6 billion won ($11.1 million) by exportin...
by Jeong Sae-im
|
2020-05-08 12:01
라인
Abclon’s affibody neutralizes Covid-19 virus
Abclon, a company specializing in antibody therapeutics, said Thursday that...
by Shim Hyun-tai
|
2020-05-07 18:50
라인
ISU Abxis’ US partner gets EU patent for hemophilia B drug
ISU Abxis said that the company’s U.S. partner Catalyst Biosciences has acq...
by Lee Han-soo
|
2020-05-07 11:22
라인
Daewoong confirms 99% cure rate in trial of gastric acid blocker
Daewoong Pharmaceutical said that it has confirmed that fexuprazan, its gas...
by Lee Han-soo
|
2020-05-06 13:54
라인
Anticipation for Korean BTX approval in China grows strong
The pharmaceutical industry is closely watching whether a Korean botulinum ...
by Jeong Sae-im
|
2020-05-06 11:53
라인
JW Pharma launches hemophilia A preventive drug in Korea
JW Pharmaceutical said Wednesday that it has launched Hemlibra (ingredient:...
by Lee Han-soo
|
2020-05-06 11:04
라인
Huons to start trials for BTX in China
Huons Global said that China’s National Medical Products Administration Cen...
by Lee Han-soo
|
2020-05-04 11:30
라인
Boryung to be transformed into anticancer drugmaker
Boryung Pharmaceutical elevated its anticancer headquarters, which were pre...
by Jeong Sae-im
|
2020-05-04 10:37
라인
‘Kisqali can treat premenopausal breast cancer patients without removing ovaries’
“In Asia, where women get breast cancer far younger than in the West, the s...
by Shim Hyun-tai
|
2020-05-01 16:45
라인
Korean drugmakers’ Q1 earnings rose despite Covid-19
Leading domestic pharmaceutical companies recorded robust earnings in the f...
by Jeong Sae-im
|
2020-05-01 14:45
라인
Kolon to return $12.3 million upfront payment to Mundipharma
Kolon Life Science said it would return 15 billion won ($12.3 million) upfr...
by Jeong Sae-im
|
2020-05-01 11:23
라인
GC’s Q1 profit surged amid Covid-19
The GC Group said Wednesday that it recorded 6.1 billion won ($5 million) i...
by Shim Hyun-tai
|
2020-04-29 18:14
라인
Court rejects Medytox’ request to stop administrative order on BTX suspension
A local court has turned down Medytox’s appeal for suspending the execution...
by Jeong Sae-im
|
2020-04-29 17:11
라인
‘Keytruda alone works as first-line therapy for lung cancer’
MSD’s immunotherapy Keytruda (ingredient: pembrolizumab) should be a standa...
by Kim Yun-mi
|
2020-04-29 11:40
라인
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
SillaJen said a combination of its oncolytic viral therapy Pexa-Vec (JX-594...
by Jeong Sae-im
|
2020-04-28 17:35
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top